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EVIDENCE has been produced that the prolonged administration of 19-nor-
progesterone (19-nor-P) may cause ovarian granulosa-cell tumours in BALB/c
mice (Lipschutz, Iglesias and Salinas, 1962. 1963). Among 33 animals with
subcutaneous pellets of 19-nor-P and an absorption of an average of 15 ,ug/day
during 13 months or more, there were 8 animals with ovarian growths, one ofthese
bilateral. Both the large and small growths were granulosa-cell tumours (G).
All the small growths occupied a peripheral site (Fig. 1, 2). One may be inclined
to assume that the evolution of the G as induced by 19-nor-P starts, or may start.
with the proliferation ofthe germinal epithelium. One ofthe large tumours found
in an animal treated with 19-nor-P for 621 days was transplanted into 6 normal
animals taking in all of the latter and surviving now in the 16th generation.
The question arises whether this quite unexpected neoplastic faculty of a
gestagen is inherent only to the synthetic 19-nor-compound or whether it is
inherent also to the natural P. This question is of considerable interest. The
body is able to transform steroids into 19-nor compounds as happens with the
production of oestrogens. The progestational activity of 19-nor-P is ten to
twenty times that of P and one wonders why then the body gives preference to
P and not to 19-nor-P. Thus we thought that knowledge of the comparative
neoplastic faculties of P and 19-nor-P would be of interest both from a physio-
logical and pathological point of view. This is why we decided to undertake a
quantitative study of the neoplastic faculties of P.
So far as we know the only paper dealing with the question whether proges-
terone may in some way influence ovarian tumorigenesis is that of Jabara (1962).
She produced evidence that the tumorigenic action of stilboestrol on the ovary
of the dog (Jabara, 1959) was not influenced by the simultaneous administration
ofprogesterone; this was probably due. as the author argues, to the animals being
given too small a quantity of progesterone (Jabara, 1962, p. 150).
Experiments with the prolonged administration of different quantities ofprogesterone
Pellets of P were implanted subcutaneously into 2 months old mice BALB/c.
The pellets contained 20 or 40 per cent of P mixed with cholesterol. Pellets
containing 100 per cent of P also were used. Additional pellets were implanted
every 3 months. In one of the groups with 100 per cent pellets of P implantation
of additional pellets was made every 2 months. At the end of experiments the
pellets are often found covered with a thin layer of tissue; the weight of a pelletTUMOURS INDUCED IN MICE BY PROGESTERONE
lhaving remained for a long time in the body may be even greater than before.
For the purpose of determining the total quantity of the steroid adsorbed the
following procedure was used. All the removed pellets of a given group ofanimals
were mixed together, dried, triturated and extracted repeatedly with ether. The
quantity absorbed corresponds to the difference between the initial weight of the
pellets and the quantity soluble in ether present in the removed pellets. For
details of calculation with 20 or 40 per cent P pellets see former work (Fuenzalida.
1950; Fuenzalida and Lipschutz, 1953).
Antiluteinizing action ofprogesterone
The antiluteinizing action of P acquires new interest when discussing the
problem of P as a contraceptive; the inhibition of ovulation and luteinization by
P is implicitly a contraceptive action. As well known, this indeed does not mean
that all contraceptive steroids are acting in the same way as P. For an exhaustive
summary on progesterone as an antifertility agent we refer to Pincus (1965).
Table I summarizes comparative observations on luteinization in normal
aniimals and in animals receiving variable quantities of P.
TABLE I. Corpora Lutea in Normal Animals of Variable Age, and in
Animals with Variable Quantities ofP
Number of animals
Duration Age at
P of treatmenit necropsy With corpora With corpora
jig./day (months) (months) Total lutea lutea 0/
o 0 11 . 26 2.5 96
0 0 . 13 24 19 79
0 0 15 12 10 83
0 0 21 33 9 27
9-18 18 20 . 32 9 28
29 18 21 44 0 0
59-900 18 21 83 0 0
The antiluteinizing activity of P becomes evident in aged animals in experi-
inents with 29 ,ig./day of P.
The decline of frequency of corpora lutea in normal aged mice also is remark-
able. In work with rats 20 out of 24 animals 607 to 1156 days old, i.e. 93 per cent
of the group, still contained corpora lutea (Mandl, 1959).
Absence of neoplastic ovarian changes in mice treated for 13 months with P
In our former work with 19-nor-P treatment was in some animals for 13
months, i.e. the greater part of the reproductive life span. After the removal of
the pellets tumours were found unexpectedly in one of these animals 47 days later
and in 2 animals 227 days later (Lipschutz, Iglesias and Salinas, 1963, Tables 5
and 7, animals 4, 6 and 7). Thus the first step made in our experiments with P
was sacrificing a group of animals which had been treated with large quantities
of P during 13 months.
The group was of 31 animals receiving 117 to 900 ,tg./day; the animals were
killed after a treatment of 397 days. There was, in this group, not a single animal
with corpora lutea (Table II). Neither was there in these animals any sign of
ovarian growth. On the contrary, when treatment was continued for 18 months
6
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TABLE II.-Ovarian Growths in Animals Treated with Pfor a Variable Time
Number of animals
Duration Age at
P of treatment necropsy With ovarian With corpora
pg./day (months) (months) Total growths lutea
117-900 . 13 15 31 0 0
59-900*. 18 . 20 . 73 23 0
* For details see Table III.
ovarian growths, though of a very variable size, occurred in a considerable
number of animals, even with smaller quantities of P than in the group treated
for 13 months.
The shortest duration of an experiment in which an ovarian granulosa-cell
tumour (G) was seen, was of 492 days. We shall come back to this experiment in
the following section.
Neoplastic Ovarian Changes in Animals Treatedfor 18 Months
with Variable Quantities ofP
The ovarian neoplastic changes have been classified in former work with
intrasplenic, intrahepatic and intrarenal ovarian grafts as macro- and micro-
tumours, according to their " index " (Lipschutz, Panasevich and Cerisola, 1964;
Lipschutz, Panasevich, Cerisola and Alvarez, 1964). However, to facilitate
classification in the present work it became necessary to make use of two addi-
tional notations: (1) not only " microtumour " but micro-I andmicro-II, according
to their size; and (2) proliferation of the germinal epithelium (PGE). These
additional notations are necessary owing to the fact that the evolutional pattern
of the granulosa-cell tumour (G) as induced by steroids-19-nor-P and now also
P-is different from the evolutional pattern of G in intrasplenic, intrahepatic,
intrarenal and intretesticular grafts. There is no transitional luteomatous phase
due to the proliferation of cells as present in the ovarian stroma; the tiny micro-II
start as G. The microtumours induced by 19-nor-P and so also by P, as already
mentioned, always occupy a peripheral site. In some cases there is also a prolifera-
tion of the germinal epithelium (Fig. 5, 6). lndeed, these tiny structures are
microscopically not coincident with the tiny micro-II tumours (Fig. 8. 16).
The index, in mm2, is the surface ofthe supposedlylargest section ofthe growth.
The determination of the index, as in former work, was made comparatively in
two different ways: (1) by direct measurement beneath the microscope, and (2) by
cutting the growth out of the photo and weighing it. With microtumours the
results obtained in the two ways are more or less coincident, and the more rapid
way (1) in general suffices. Both procedures are certainly far from being exact
but they are very helpful for the orientation both of the worker and the reader.
The indices ofG tumours ofdifferent size, in mm2, are given at the top ofTable III.
Results obtained in animals treated for 18 months with variable quantities of
P are summarized in Table III; some of these animals, indeed without any
details, have already been mentioned in Table 11.
A small micro-I was found also among the 33 normal animals (Fig. 3). The
comparative incidence of growths in 33 normal aged animals, and in 76 animals
receiving 9 to 29 ,ug./day of P, is not significant; all the more as 2 out of the 5
cases in the 9 to 29 ,ug. groups are no more than tiny nodules of the proliferatedTUMOURS INDUCED IN MICE BY PROGESTERONE
TABLE III.-192 Animals. Treatment: 18 Months. Age at Necropsy: 20-21 Months.
For Exceptions (11 Animals) see * and t
Number of animals
G Proliferation
With macro G G of germinal
P With growths 5 0 or micro I micro II epithelium
jig./day Total growths % more (05-<5-0) (<0 5) (PGE) Fig.
0 .33 1 3 0 1 0 0 3
9-18 32 2 6-3 4§ 0 1 0 1 . 4,3
29 . 44 3 6 8f 0 0 2 1 6, 7
59 . 28 7 25- 0 1 1 5 0 8
117 19* 7 36-9 2 2 3 0 9-11
665 . 20 lOt 50 0 0 4 6 0 12-16
900 16 3 18-8 0 0 3 0 . 17
* Including 4 animals of Table IV, group 2a, reaching 25 months. Pellets were removed after
a treatment of 18 months. There were no ovarian changes in these 4 animals.
t Including 6 animals of Table IV, group 2a, reaching 23 months after a treatment of 18 months.
There were 4 animals (out of 6) with micro-II, one of which bifocal, and 1 trifocal (Fig. 19). 1 animal
treated only 492 days, reaching the age of 564 days, with micro-I (Fig. 12).
+ 2 animals with bilateral G (Fig. 14, 1a) and 1 bifocal, besides those mentioned in t.
§ Omitting PGE.
germinal epithelium to which we referred above (Fig. 5, 6). When omitting these
2 cases there remain in these groups of a total of 76 animals only 3 G, i.e. only
4 per cent. However, one wonders whether in Fig. 6 there is already a transitional
condition from PGE to micro-II G. There was indeed in the 9 ,tg./day group
also a micro-I G with an index of about 4 mm. but thus occupying almost the
whole ovary (Fig. 4). In the 29 ,ug./group there were besides PGE (Fig. 6) also
2 micro-II G (Fig. 7).
With 59pg./day the incidence of G increases considerably. No less than 7
out of 28 animals have G tumours: 1 macro G with an index of 9.5, 1 micro-I
and 5 micro-Il G. The dimensions of two of the latter are somewhat larger than
Fig. 7; but the remaining 2 growths are as to their size not very far from PGE
(Fig. 8 ( x 310); compare Fig. 6 ( x 195)).
There is a further considerable increase when the available quantity of P
reaches 117 ,ug./day: 2 macro G (Fig. 9, 10), 2 micro-I (Fig. 11) and 3 micro-Il).
Somewhat different is the condition in the group with 665 ,ug./day. There
were 4 micro-I (Fig. 12, 13, 14) and 6 micro-II (Fig. 15, 16). In one of these
micro-1I (Fig. 15) the order of the cells was as typical as in the macro G (Fig. 9B,
lOB); another micro II (Fig. 16) was but a minute nodule similar to Fig. 8. The
differences between the 117 ,ug./day group and the 665/ig./day group were the
following: (1) there were in the 665-group no macro G; (2) there were in the latter
2 cases with bilateral microtumours (Fig. 14, 15).
When comparing the 117 and 665 ,ug./day series one has the contradictory
feeling that the neoplastic reaction taken as a whole has diminished with the
considerable increase of P per day. This is indeed a very vague feeling. But
the latter becomes stronger when comparing results with 665 and 900 ,tg./day.
There were among 16 animals with 900 ,ug./day only 3 with G; all were micro-II
(Fig. 17). However, the structure of these 3 micro-II G was as ever coincident
with that of macro G and micro-I G in the preceding groups.
One may ask whether the tumorigenic action of P goes parallel with the anti-
luteinizing one. When comparing Table III with Table I it might seem that some
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tumorigenic action becomes established before the antiluteinizing one is completed
(9-18 ,ug./day). But as already insisted upon, the increase of tumour incidence
in this group and in the following 29 ,tg./day group, compared to normal animals,
is not significant. We shall also see in one of our next papers that in experiments
with 19-nor-contraceptives G may appear when corpora lutea are still present.
Tumours appearing after the removal ofprogesterone pellets
As already mentioned, tumours appeared in experiments with 19-nor-P a
certain time after the removal of pellets which had been present in the body for
13 months. In our work with P pellets were removed after a treatment of 13 and
18 months. Results with 24 animals surviving for many months the end of the
treatment are given in Table IV (la and 2a).
In experiments with a treatment of only 13 months (la) and a long survival
after the removal ofthe pellets there was one animal with a typical macro G with
an index of 12. A micro-I was present in the second animal (Fig. 18).
In 2a with a survival of various months after a treatment of 18 months the
incidence was the same as in 2b, i.e. in animals killed at the end ofthe treatment.
In other words, no increase of tumour incidence was obtained by increasing the
EXPLANATION OF PLATES
FIG. 1. Animal 510 days, 15 ,ug./day of 19-nor-P (6101). Autopsied 103 days afterwards.
There was a large turnour (index 20) in one ovary; a minute focus (proliferation ofgerminal
epithelium?) in the other ovary as shown in this figure. A, x 34. B, X 390.
FIG. 2.-Micro-I G. 395 days, 15 pg./day 19-nor-P (5773). Autopsied 227 days afterwards.
Index 0 5. Pronounced lobular structure. A, x 34. B, X'390.
FIG. 3.-Micro-I G, in a normal animal (8155). Index 0-5. Compare cells of micro G with
follicular granulosa cells. A, X 34. B, X 195.
FIG. 4. Micro-I G. 531 days, 9 ,ug./day P (8058). Index 3-8. Border of G, surrounded by
haematoma. A, x 13. B, X 195.
FIG. 5.-Proliferation of germinal epithelium. 554 days, 18 psg./day P (8084). x 195.
FIG. 6. Proliferation of germinal epithelium. 548 days, 29 psg./day P (8306). x 195.
FIG. 7.-Micro-I G. 548 days, 29 ,ug./day P (8338). Index 0-2. Lobulated structure. Cells
frequently arranged in such a way as to give the impression of piles of coins. A, X'34.
B, X 195.
FIG. 8. Minute micro-II; proliferation of germinal epithelium (?). 552 days, 59 ,ug./day P
(8417.). Index 0-03. (Compare with Fig. 16.) X 310.
FIG. 9.--Macro G. 550 days, 117 ,ug./day (8936). Index 12-8. A, x34. B, x 195.
FIG. 10. Macro G. 552 days, 117 p4g./day P (8912). Index 8-7. Partly covered by ovarian
tissue. A, x 13. B, X 390.
FIG. 11.-Micro-I G. 564 days, 117 pzg./day P (8935). Index 3-7. A, x 13. B, x390.
FIG. 12. Micro-I G. 492 days, 665 ,ug./day P (8836). Index 1-3. x 195.
FIG. 13.-Micro-I G. 554 days, 665 ,ug./day P (8840). Index 0-6. Haemorrhagic swamp.
Note the structure of the cells covering the swamp. A, X 34. B, X 195.
FIG. 14. One of the two micro G. 554 days, 665 pzg./day P (8864). Bilateral. Index 0-2.
The two structurally different regions of the nodule. A, X 34. B, X 195.
FIG. 15.-One of the two micro G. 554 days, 665 ,ug./day P (8843). Bilateral. Index 0-06.
The minute nodule is structurally a G tumour. A, X 98. B, X 390.
FIG. 16. Minute micro-II; proliferation of germinal epithelium (?). 554 days, 665 ,ug./day
(8869). Index 0-01. (Compare with Fig. 8.) x390.
FIG. 17. Micro-Il G. 553 days, 900 psg./day P (9060). Index 0-2. Very pronounced lobular
structure. x 98.
FIG. 18.-Micro G. 397 days, 665 ,ug./day P (8831). Trifocal. Survival of 227 days after
removal of pellets. One large nodule with pronounced lobular structure; two nodules of
minor size, to the right of the larger one. Index of the 3 foci together 1-3. x 34.
FIG. 19.-Micro G. About 18 months, 665 ug./day P (8859). Trifocal. Survival of 5i
months after the last implantation. Index ofthe 3 foci together 0-7. Large focus on the top
and small focus on the right. x 34.BRITISII JOURNAL OF CANCER.
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TABLE IX.-24 Animals with Pellets ofP. Pellets were Removed After a Treatment
of 13 and 18 Months. To be Compared With Table III.
Duration Survival
of after removal Age Number of animals
P treatment of pellets at death ,_ X__
,ig./day (months) (months) (months) Total With G Fig.
la. 117-900. 13 . 6-9 . 21-25 . 13 2 .18
lb. 117-900. 13 0 . 15-16 . 32 0
2a. 117-665. 18 2*-4j . 23-25 10 4 .19
2b 117-665. 18 0 . 20-21 . 29 13
* See also Table IlIt. In the 6 animals with 665 ,ug./day there was no removal of pellets; but
at 18 months the animals were allowed to live for 21 months more without any new implantation of
pellets. In mice the 100 per cent pellet is almost completely absorbed in about 3 months. Thus
the failure of a new implantation in due time is identical with removal of pellets.
age of the animals by 2- to 4- months. Thus it would seem that it is not the
age which could be responsible for the differential results with a treatment of
13 and 18 months (lb and 2b); the difference seems to be due just to the duration
of treatment. Indeed, age may be responsible for a more ample growth of G
induced by P; this would explain both the appearance ofa macro G in la and the
unique picture ofthe trifocal growth in la and 2a (Fig. 18 and 19). The question
whether the difference between la and lb is significant and whether there is an
after-effect of P is certainly of fundamental pathological interest and should be
studied in a much greater number of animals.
DISCUSSION
There is no doubt that the prolonged administration of P can produce ovarianl
granulosa-cell tumours in mice. The question how far the incidence might depend
on spontaneously occurring G in this or in other strains is of no avail because the
experiments related in this paper give full evidence that the incidence ofG increases
(1) with the quantity of P administered, and (2) with the duration of treatment
with P. In our work the administration of P was a continuous one; it is but
reasonable to raise the question how far the continuity of the action of P might
have contributed to the results obtained. The question is of considerable interest
when discussing the tumorigenic faculties of steroids; the fibromatogenic action
of oestrogens fails when the latter are administered rhythmically, i.e. discon-
tinuously (Lipschutz, Rodriguez and Vargas, 1941; Lipschutz, 1950, pp. 40-41).
Our results give full evidence that the neoplastic faculty ofP is greatly inferior
to that of 19-nor-P. Even with 117 ,Ig./day administered during 18 months the
tumorigenic result is less pronounced thanwith 15 ,tg./dayof 19-nor-Padministered
during 13 to 17 months. Thus one may argue that it was truly the " Wisdom of
the Body ", to use the words of Cannon (1932), giving preference to P and not to
the more active 19-nor-P; any quantitative or timing lapse would mean in the
case of the latter a considerable danger for the ovary.
Granulosa-cell tumours have been produced experimentally grafting the ovary
into the spleen in rats (Biskind and Biskind, 1944), in mice (Li and Gardner,
1947; Gardner, 1955, 1961; Furth and Sobel, 1947), in guinea-pigs (Mardones,
Iglesias and Lipschutz, 1955; summaries Lipschutz, 1950, 1957), and in rabbits
(Peckham, Greene and Jeffries, 1948; Peckham and Greene, 1952). The evolution
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of these experimental ovarian tumours in mice and guinea-pigs also has been
studied and summarized by various authorities (Guthrie, 1957, 1959; Kullander,
1954, 1956, 1959; Lipschutz, 1957, 1960, 1963; Lipschutz, Rojas, Cerisola and
Iglesias, 1960; Lipschutz, Panasevich, Cerisola and Alvarez, 1965). The final
structure of G induced by 19-nor-P or by P is apparently coincident with that of
G in intrasplenic grafts. However, the evolution of G originating under the
influence of 19-nor-P or P is fundamentally different from that of G originating
in intrasplenic ovarian grafts. In intrasplenic ovaries the growth originates in
the overwhelming number of cases from cells as present in the ovarian stroma;
the growth is primarily a luteoma which subsequently changes into G. On the
contrary, the growth arising under the influence of the mentioned steroids is
from the start a granulosa-cell tumour located, when still a microtumour, in the
periphery or even on the surface of the ovary.
Since there is in some cases a proliferation of the germinal epithelium the
question arises whether the latter partakes in the evolution ofthese steroid-induced
granulosa-cell tumours. One will remember that according to Gardner (1955)
even the granulosa-cell tumours in the intrasplenic grafts " appeared to arise
from the germinal epithelium " (p. 116). Indeed, most of those who have worked
with intrasplenic grafts were rather in favour of the cells of the stroma or of the
theca being the matrix of the growth in intrasplenic ovarian grafts (Kullander,
1959; Guthrie, 1957; Lipschutz, 1960). The same seems to be true also for the
microtumours originating in the kidney and the liver (Lipschutz, Panasevich and
(erisola, 1964).
The implication of P in tumorigenesis has been known for several years;
evolution of mammary cancer in rats treated with a carcinogen is enhanced when
P is added (Cantarow, Stasney and Paschkis, 1948; Huggins, Briziarelli and
Sutton, 1959). More recently the question has been re-examined in mice bv
Poel (1965) with impressive results. There is no doubt that P may act as a
potent co-carcinogen for mammary cancer when administered together with
methylcholanthrene; incidence of the mammary tumour as induced by the
carcinogen was 21 per cent but increased to 100 per cent when P was given
simultaneously (Poel, 1965, p. 827). In the work of Poel, in mice no more than
2-5 ,ug./day of P in peanut oil were administered. In former work in rats more
than 200 /ug./day were injected intramuscularly (Cantarow et al., 1948, p. 412), or
about 25 to 30 ,ug./day when calculating for mice. On the other hand, our work
gives full evidence that under certain quantitative and timing conditions P mav
produce ovarian tumours independently from any carcinogen. The tumorigenic
quantities of P in absence of any carcinogen are indeed several times greater than
those used in the work of the mentioned authorities.
Most interesting clinical work has been done using 17ax-hydroxyprogesterone
capronate in the treatment of malignant tumours of the breast, ovary and uterus,
with success in a number of cases (Jolles, 1962). At first sight this seems con-
tradictory to the findings both of the mentioned authorities and of ours. It is
of considerable interest to approach these problems from a quantitative point of
view. Jolles administered to his patients 250 mg. of 17Lx-hydroxyprogesterone
capronate weekly by injection for up to 3- years. This quantity administered
to patients corresponds to about 600 ,ug./day per 1 kg. of body weight, i.e. to
about 20 pg./day in mice. A quantitative comparison with continuous absorption
of P from subcutaneously implanted pellets would be difficult since the capronateTUMOURS INDUCED IN MICE BY PROGESTERONE 151
of 17a-hydroxyprogesterone is more active than P. Landau, Ehrlich and Huggins
(1962) administered to patients with advanced mammary cancer 50 mg./day of
P intramuscularly, i.e. about 30 ,ag./day when calculated for mice. This quantity
is not yet tumorigenic in mice (see our Table III). But here again comparison
is rendered difficult because in this clinical work 5 mg. of oestradiol were given
simultaneously with the mentioned 50 mg. of P. Certainly in none of these
clinical studies was the treatment so prolonged as in our mice with 13 or 18 months
when P becomes tumorigenic.
SUMMARY
Granulosa-cell tumours are induced in the ovary of mice with the prolonged
and continuous administration of progesterone.
The production of these tumours depends on the quantity of progesterone
administered and on the duration of this administration.
The incidence increases with the amount of progesterone administered.
The neoplastic faculty of progesterone is probably ten times smaller than that
of 19-nor-P.
The evolutional pattern of the steroid-induced granulosa-cell tumour is
different from that of the same tumour originating in intrasplenic grafts:
(1) The steroid-induced ovarian tumour is from the start a granulosa-cell
tumour whereas in grafts the same tumour is preceded by a luteoma arising from
the proliferation of cells as present in the ovarian stroma.
(2) The steroid-induced granulosa-cell tumour arises in the periphery of the
ovary and one cannot avoid questioning whether, besides the follicle, also the
germinal epithelium partakes in this neoplastic proliferation.
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